Gender-based differences have been shown to affect the prognosis of various tumors, but their role in the survival of rectal neuroendocrine tumors (RNETs) remains unclear.
Therefore, we aimed to explore the gender-based differences in the prognosis of RNETs using the Surveillance, Epidemiology, and End Results (SEER) database.
